EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ABSI: Absci Corp

28 Nov 25 08:53
LAST:

3.110

CHANGE:
 0.02		OPEN:
3.100		HIGH:
3.180		ASK:
0.000		VOLUME:
17.6K
CHG(%):
0.48		PREV:
3.095		LOW:
3.100		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
28 Nov 253.1003.1803.1003.11017.6K
26 Nov 253.0803.1403.0003.0902.84M
25 Nov 252.9603.0802.9003.0703.68M
24 Nov 252.9503.0202.8802.9652.69M
21 Nov 252.7702.9702.7052.9304.05M
20 Nov 252.9503.1102.7602.7706.0M
19 Nov 252.8703.0652.8602.8603.43M
18 Nov 252.8102.9002.7302.8404.51M
17 Nov 252.7903.0702.7602.8605.13M
14 Nov 252.6102.9902.6102.8207.3M

PROFILE

Name:Absci Corp
About:Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Sector:Healthcare
Industry:Biotechnology
Address:18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683
Website:https://www.absci.com
CUSIP:00091E109
CIK:0001672688
ISIN:US00091E1091
FIGI:BBG011N54CJ8

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-4.37 
Forward P/E:-6.03 
PEG Ratio:-0.48 
Price to Sales:154.65 
Price to Book:3.15 
Operating Margin:-52.94 
Return on Assets:-0.31 
Return on Equity:-0.57 
EPS Ratio:-0.95 
Revenue:4.14M 
Shares:149.52M 
Market Cap:465.02M 

TECHNICAL INDICATORS

MA5:3.042.4%
MA10:2.936.0%
MA20:3.264.8%
MA50:3.5614.5%
MA100:3.171.9%
MA200:3.100.5%
STO9:87.80 
STO14:53.27
RSI14:43.84
WPR14:-39.51
MTM14:-0.19
ROC14:-0.06 
ATR:0.27 
Week High:3.182.3%
Week Low:2.7115.0%
Month High:4.5345.7%
Month Low:2.600.5%
Year High:6.33103.5%
Year Low:2.0154.7%